Vanessa A. N. Kraft

Vanessa A. N. Kraft

Auto-generated profile, based on publicly available information

Vanessa A. N. Kraft

Genetics and Cellular Engineering Group, Institute of Molecular Toxicology and Pharmacology, Helmholtz Zentrum Munich, Neuherberg, Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2019 in ACS Central Science
Verified
Journal Article
Open access
VKVanessa A. N. Kraft
Vanessa A. N. Kraft
CBCarla T. Bezjian
Carla T. Bezjian
SPSusanne Pfeiffer
Susanne Pfeiffer
LRLarissa Ringelstetter
Larissa Ringelstetter
CMConstanze Müller
Constanze Müller
JSJoel Schick
Joel Schick
Ferroptosis is an iron-dependent form of regulated cell death linking iron, lipid, and glutathione levels to degenerative processes and tumor suppression. By performing a genome-wide activation screen, we identified a cohort of genes antagonizing ferroptotic cell death, including GTP cyclohydrolase-1 (GCH1) and its metabolic derivatives tetrahydrobiopterin/dihydrobiopterin (BH4/BH2). Synthesis of BH4/BH2 by GCH1-expressing cells caused lipid remodeling, suppressing ferroptosis by selectively preventing depletion of phospholipids with two polyunsaturated fatty acyl tails. GCH1 expression level in cancer cell lines stratified susceptibility to ferroptosis, in accordance with its expression in human tumor samples. The GCH1-BH4-phospholipid axis acts as a master regulator of ferroptosis resistance, controlling endogenous production of the antioxidant BH4, abundance of CoQ10, and peroxidation of unusual phospholipids with two polyunsaturated fatty acyl tails. This demonstrates a unique mechanism of ferroptosis protection that is independent of the GPX4/glutathione system.

18 October 2021 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
SXShan Xin
Shan Xin
CMConstanze Mueller
Constanze Mueller
SPSusanne Pfeiffer
Susanne Pfeiffer
VKVanessa A. N. Kraft
Vanessa A. N. Kraft
JMJuliane Merl-Pham
Juliane Merl-Pham
JSJoel Schick
Joel Schick
Ferroptosis is an iron-dependent form of cell death driven by biochemical processes that promote oxidation within the lipid compartment. Calcium (Ca2+) is a signaling molecule in diverse cellular processes such as migration, neurotransmission, and cell death. Here, we uncover a crucial link between ferroptosis and Ca2+through the identification of the novel tetraspanin MS4A15. MS4A15 localizes to the endoplasmic reticulum, where it blocks ferroptosis by depleting luminal Ca2+stores and reprogramming membrane phospholipids to ferroptosis-resistant species. Specifically, prolonged Ca2+depletion inhibits lipid elongation and desaturation, driving lipid droplet dispersion and formation of shorter, more saturated ether lipids that protect phospholipids from ferroptotic reactive species. We further demonstrate that increasing luminal Ca2+levels can preferentially sensitize refractory cancer cell lines. In summary, MS4A15 regulation of anti-ferroptotic lipid reservoirs provides a key resistance mechanism that is distinct from antioxidant and lipid detoxification pathways. Manipulating Ca2+homeostasis offers a compelling strategy to balance cellular lipids and cell survival in ferroptosis-associated diseases.

30 June 2020 in Molecular Oncology
Verified
Journal Article
Open access
PDF file
LYLimeng Yang
Limeng Yang
VKVanessa A. N. Kraft
Vanessa A. N. Kraft
SPSusanne Pfeiffer
Susanne Pfeiffer
JMJuliane Merl-Pham
Juliane Merl-Pham
XBXuanwen Bao
Xuanwen Bao
JSJoel Schick
Joel Schick
Nonsense‐mediated decay (NMD) proteins are responsible for the surveillance and degradation of aberrant RNAs. Suppressor with morphogenetic effect on genitalia 7 (SMG7) is an NMD complex protein and a regulator of tumor necrosis factor (TNF)‐induced extrinsic apoptosis, however, this unique function has not been explored in detail. In this study, we show that loss of Smg7 leads to unrestricted expression of long non‐coding RNAs (lncRNAs) in addition to NMD targets. Functional analysis of Smg7 ‐/‐ cells showed downregulation of the tumor suppressor cylindromatosis (CYLD) and diminished caspase activity, thereby switching cells to nuclear factor‐κB (NF‐κB)‐mediated protection. This positive relationship between SMG7 and CYLD was found to be widely conserved in human cancer cell lines and renal carcinoma samples from The Cancer Genome Atlas (TCGA). In addition to CYLD suppression, upregulation of lncRNAs Pvt1 and Adapt33 rendered cells resistant to TNF, while pharmacologic inhibition of NF‐κB in Pvt1‐ overexpressing TNF‐resistant cells and Smg7 ‐deficient spheroids re‐established TNF‐induced lethality. Thus, loss of SMG7 decouples regulation of two separate oncogenic factors with cumulative downstream effects on the NF‐κB pathway. The data highlight a novel and specific regulation of oncogenic factors by SMG7 and pinpoint a composite tumor suppressor role in response to TNF.